Global Moderate-to-Severe Acne Treatment Industry is set to expand significantly, reaching US$ 2.4 billion by 2033, propelled by a CAGR of nearly 6.2%, as per FMI

Moderate-to-Severe Acne Treatment Market

In 2023, the global moderate-to-severe acne treatment industry demand was estimated at US$ 1.3 billion, and by 2033, it is anticipated to grow to US$ 2.4 billion. With a value share of around 25.6%, retinoid therapy led the global market in the treatment category in 2022. From 2023 to 2033, it is anticipated to rise at a CAGR of nearly 6.2%.

The moderate-to-severe acne treatment market has witnessed significant growth in recent years, driven by the increasing prevalence of acne and the growing demand for effective solutions. Acne, a common dermatological condition, can have a profound impact on an individual’s self-esteem and quality of life, particularly when it reaches moderate-to-severe stages. This has led to a surge in research and development activities aimed at creating advanced treatment options that target not only the visible symptoms of acne but also its underlying causes.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-8095

Several factors have contributed to the expansion of this market. One of the primary drivers is the rising awareness among the global population about skincare and the availability of various treatment alternatives. Technological advancements have led to the development of innovative therapies, including topical and oral medications, phototherapy, chemical peels, and laser treatments, tailored specifically for moderate-to-severe acne cases. These treatments offer faster and more comprehensive results, addressing both inflammatory lesions and potential scarring.

Furthermore, the influence of social media and the beauty industry has played a role in boosting the demand for acne treatment products and services. The increasing emphasis on clear, blemish-free skin has prompted individuals to seek out medical interventions to tackle their skin concerns more effectively. As a result, dermatology clinics, aesthetic centers, and even traditional healthcare providers have witnessed a growing number of patients seeking professional assistance for their moderate-to-severe acne issues.

However, challenges persist within the market. The diversity of patient needs, varying skin types, and potential side effects associated with certain treatments require a cautious and personalized approach. Additionally, regulatory hurdles and reimbursement issues can affect the accessibility of advanced treatments, particularly in some regions. Despite these challenges, the moderate-to-severe acne treatment market remains dynamic and competitive, driven by continuous research, collaboration between dermatologists and pharmaceutical companies, and the increasing demand for improved quality of life among acne sufferers.

Key Takeaways from Market Study:

  • By treatment, retinoid therapy accounts for US$ 318.9 Million in 2022 owed to the benefits provided which includes novel formulations, combination therapies, and improved delivery systems, providing patients and healthcare professionals with a wider range of options.
  • By route of administration, topical accounts for more than 45% in 2022 globally. Topical acne treatments are available both over-the-counter (OTC) and by prescription. While milder acne may be managed with OTC options, moderate-to-severe acne often requires prescription-strength topical treatments.
  • Hospitals holds about 9% of the global market share in 2022. Hospitals may conduct clinical trials and research studies related to acne treatment, including moderate-to-severe cases. These studies contribute to the development of new therapies and advancements in the field of acne treatment, helping to shape the market landscape.
  • By region, North America held dominant share in world in 2022. North America has a strong emphasis on aesthetic dermatology, including the management of acne and acne scarring. There is a demand for treatments that not only address acne but also improve the appearance and texture of the skin. This drives the availability of cosmetic procedures and innovative technologies for acne treatment.

“The rising cases of skin & acne disorders and increased in adoption rate of therapies contribute to its higher demand and global expansion.” says an analyst of Future Market Insights.

Our Analyst Is Available To Help You With Any Inquiries Reach Out Anytime! https://www.futuremarketinsights.com/ask-question/rep-gb-8095

Market Competition:

The leading companies are increasing their research & development investments in an effort to create innovative and inventive care with enhanced effectiveness, and affordability. With key focus on expanding their products, companies are strengthening their sales channels in emerging countries.

  • In January 2023, the manufacturing plant owned by Abzena in Sanford, North Carolina, was announced to be purchased by Pfizer, according to an agreement the two firms announced.
  • In May 2023, Roche’s India division purchased more than 200,000 square feet of office space with Brookfield Properties in the company’s commercial project in Pune’s Baner area.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the moderate-to-severe acne treatment market in its latest study, presenting a historical demand assessment of 2017 – 2022 and projections for 2023 – 2033. The global moderate-to-severe acne treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader

The analysis is based on treatment (antibiotics, retinoid therapy, hormonal drugs, anti-inflammatory drugs, chemical peels, laser devices and radiofrequency devices), route of administration (oral, topical and Injectables), and distribution channel (hospitals, clinics, pharmacies & drug stores, e-Commerce and others), across seven key regions around the world.

Key Companies Profiled:

  • Johnson & Johnson
  • Bayer AG
  • Galderma
  • Allergan
  • Roche
  • Valeant Pharmaceuticals
  • Stiefel Laboratories
  • Pfizer
  • Foamix Pharmaceuticals
  • La Roche-Posay
  • Proactiv
  • Cipla Limited
  • GlaxoSmithKline Inc.
  • Janssen Pharmaceuticals Inc.
  • Sanofi

Discover the Future of Marketing: Get Your Hands on Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-8095

Key Market Segments Covered in the Moderate-to-Severe Acne Treatment Industry Research:

By Treatment:

  • Antibiotics
  • Retinoid Therapy
  • Hormonal Drugs
  • Anti-Inflammatory Drugs
  • Chemical Peels
  • Laser Devices
  • Radiofrequency devices

By Route of Administration:

  • Oral
  • Topical
  • Injectables

By Distribution Channel:

  • Hospitals
  • Clinics
  • Pharmacies & Drug Stores
  • e-Commerce
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Excited: This Is Your Chance To Dive Into A Treasure Trove Of Market Insights. Purchase Now And Unleash The Potential Of Your Business! https://www.futuremarketinsights.com/checkout/8095

Explore FMI’s related ongoing Coverage on Healthcare Market Domain:

Leukotriene Modifiers Market Size: The global leukotriene modifiers market was anticipated to reach a valuation of US$ 21.9 Billion in the year 2022. With a steady CAGR of 5.3% from 2023 to 2033, this market is expected to reach US$ 23.06 Billion by 2023 and US$ 38.65 Billion by 2033.

Cardiogenic Shock Treatment Market Share: The global Cardiogenic Shock Therapy Market is projected to reach a market size of US$ 0.9 billion in 2023 and US$ 1.77 billion by 2033, growing at a CAGR of 7% during that time.

Intrauterine Insemination Devices Market Growth: The market for intrauterine insemination products is anticipated to be worth US$ 40.5 million in 2023 and US$ 57.5 million by 2033. Devices for intrauterine insemination are anticipated to be in high demand, with a 3.6% CAGR.

Blood Volume Analyzer Market Demand: In 2022, it was projected that the market for blood volume analyzers will be worth US$4.4 billion. This market is anticipated to reach US$ 4.81 billion by 2023 and US$ 11.82 billion by 2033 with a consistent CAGR of 9.4% from 2023 to 2033.

Bronchiectasis Therapeutic Market Opportunity: In 2022, it was projected that the global bronchiectasis treatment market would be worth US$ 481.71 million. This market is anticipated to reach US$ 511 Million by 2023 and US$ 932.54 Million by 2033, with a consistent CAGR of 6.2% from 2023 to 2033.

Alcoholic Hepatitis Treatment Market Strategies: According to Future Market Insights (FMI) analysis in a recent market survey, the global alcoholic hepatitis treatment market was valued at US$ 2.6 Billion in 2022 and is expected to reach US$ 5.3 Billion by 2033.

Single-use Gastroscopes Market Outlook: According to Future Market Insights (FMI) analysis in a recent market survey, the global single-use gastroscopes market was valued at US$ 167.2 Million in 2022 and is expected to reach US$ 807.8 Million by 2033.

Celiac Disease Diagnostics Market Forecast: According to Future Market Insights (FMI) analysis in a recent market survey, the global celiac disease diagnostics market was valued at US$ 271.3 Million in 2022 and is expected to reach US$ 647.3 Million by 2033.

Extraction Kits Market Trends: The global demand for extraction kits is expected to increase at 7.1% CAGR over the forecast period. The extraction kits market size is estimated to reach a valuation of US$ 1,293.4 million by 2023. According to the study, DNA extraction kit products held a substantial share of 49.88% in 2022 in the global market.

Over-The-Counter (OTC) Veterinary Drugs Market Opportunity: The over-the-counter (OTC) veterinary drugs market is expected to expand its roots at a steady CAGR of 7.9% during the forecast period. The market is likely to hold a revenue of US$ 8.8 billion in 2023 while it is anticipated to cross a value of US$ 19.01 billion by 2033.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
[email protected]
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Health and Fitness

Global At-Home Food Sensitivity Tests Market is expected to grow at a CAGR of 8.5%, reaching US$ 547 million by 2034, as per FMI

As per our latest industry analysis, the valuation for the global at-home food sensitivity tests market demand is projected US$ 241.4 million in 2024. The overall market is projected to exhibit a CAGR of 8.5% between 2024 and 2034, with an estimated valuation of US$ 547 million by 2034. Changing dietary patterns has increased the […]

Read More
Health and Fitness

Generic Oncology Drug Industry in Europe and MENA is poised for continual growth, with projections indicating a potential rise to US$ 8.2 Billion by 2033

The generic oncology drug industry in Europe and the MENA demand region witnessed substantial revenue totaling US$ 6.5 billion in 2022, and it is projected to climb to US$ 6.7 billion by 2023. A comprehensive analysis forecasts an impressive 2.1% Compound Annual Growth Rate (CAGR) over the assessment period, indicating a surge in sales that […]

Read More
Health and Fitness

United Kingdom Dysphagia Management Industry is forecasted to attain US$ 293.3 million by 2033, backed by a consistent 2.4% CAGR, according to FMI

The United Kingdom dysphagia management industry demand anticipates a robust surge in revenue, projected to escalate from US$ 232.4 million in 2023 to an estimated US$ 293.3 million by 2033. This substantial growth is driven by an anticipated rise in demand for dysphagia management products, expected to grow at a steady Compound Annual Growth Rate […]

Read More